Valuation: Scope Fluidics S.A.

Market Cap 381M 102M 88.79M 81.6M 76.06M 144M 9.67B 146M 980M 4.75B 381M 373M 16.38B P/E 2026 *
-6.99x
P/E 2027 * 0.95x
Enterprise Value 284M 75.67M 66.15M 60.79M 56.67M 107M 7.21B 109M 730M 3.54B 284M 278M 12.2B EV / Sales 2026 *
113x
EV / Sales 2027 * -
Free-Float
77.15%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week+1.52%
Current month+1.35%
1 month-1.31%
3 months-13.53%
6 months-14.02%
Current year-11.75%
1 week 118
Extreme 118
122.4
1 month 118
Extreme 118
125
Current year 109
Extreme 109
159.2
1 year 109
Extreme 109
182.2
3 years 109
Extreme 109
239
5 years 83
Extreme 83
348
10 years 9.55
Extreme 9.55
348
Manager TitleAgeSince
Corporate Officer/Principal 52 -
Chief Executive Officer 50 -
Director of Finance/CFO 50 -
Director TitleAgeSince
Chairman 51 2017-03-06
Director/Board Member 50 2017-03-06
Director/Board Member 63 2017-03-06
Date Insider Type Main position Quantity % Market Cap.
Jan. 14Buy

Chairman

36,000 1.1363%
Jan. 14Sell

Chairman

36,000 1.1363%
Jan. 14Others

Chairman

140,000 4.4188%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+1.52%-21.34%-32.47% 102M
-4.63%-2.51%+106.96%+124.11% 4.55B
-5.27%+4.64%+84.58%+215.80% 3.39B
+2.15%+0.88%-25.09%-38.94% 2.03B
+8.56%+2.38%+146.29%-38.78% 1.92B
-0.21%+4.81%+49.77%+243.41% 1.51B
-1.79%-1.31%+127.92%-51.41% 891M
+1.38%+0.69%-10.93%+42.82% 856M
+2.32%+5.38%-34.20%-16.34% 486M
-0.83%-0.24%+1.82% - 473M
Average +0.18%+0.53%+42.58%+49.80% 1.62B
Weighted average by Cap. -1.12%+0.93%+71.94%+94.68%

Financials

2026 *2027 *
Net sales 2.5M 667K 583K 536K 499K 947K 63.49M 961K 6.43M 31.21M 2.5M 2.45M 108M -
Net income -54.4M -14.51M -12.68M -11.66M -10.87M -20.61M -1.38B -20.92M -140M -679M -54.46M -53.29M -2.34B 400M 107M 93.38M 85.82M 79.99M 152M 10.17B 154M 1.03B 5B 401M 392M 17.23B
Net Debt -97.1M -25.9M -22.64M -20.81M -19.39M -36.78M -2.47B -37.34M -250M -1.21B -97.21M -95.12M -4.18B -494M -132M -115M -106M -98.7M -187M -12.55B -190M -1.27B -6.17B -495M -484M -21.26B
Logo Scope Fluidics S.A.
Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.
Employees
157
Date Price Change Volume
26-07-03 PLN 120.20 +0.17% 643
26-07-02 PLN 120.00 -1.32% 1,995
26-07-01 PLN 121.60 +2.53% 1,499
26-06-30 PLN 118.60 0.00% 1,802
26-06-29 PLN 118.60 +0.17% 344
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
120.20PLN
Average target price
198.20PLN
Spread / Average Target
+64.89%

Annual profits - Rate of surprise